Dr June Raine, Director of Vigilance and Risk Management of Medicines at the MHRA, reports in the British Medical Journal (BMJ) on the latest guidance on monitoring the safety of drugs from the World Health Organization (WHO) focuses on planning and implementing adverse drug reaction systems for the general public and will probably make an important contribution to pharmacovigilance strategies.
↧